GROUP-B STREPTOCOCCUS - PERINATAL CONSIDERATIONS

Group B streptococcal (GBS) infections arc responsible for significant perinatal morbidity and mortality in the United States. It has been p roposed that to prevent neonatal sepsis, all pregnant women be screene d for GBS colonization, and that intrapartum antibiotics be used in ce rtain high-risk situations. These recommendations are controversial, a s is the current management of the asymptomatic newborn of a GBS-colon ized mother.